Experimental Therapeutics Research Program

The Experimental Therapeutics (Clinical/Translational) Research Program seeks to provide new and better ways to detect, diagnose, treat, and prevent disease. Successful disease-based collaborative teams include Hematologic Malignancies, Gastrointestinal Cancers, Head and Neck Cancers, and Pediatric Cancers. The Cancer Center has a strong Experimental Therapeutics program, offering cutting-edge clinical trials of novel drugs and treatment methods for cancer.

Program Aims

Check back soon for Clinical/Translational program aims.

Leadership
	Davendra Sohal, MD, MPH Associate Director for Clinical Research

Key Research Findings

Check back soon for blog posts and publications.

Members